Wuhan Coronavirus Thread

Is coronavirus a biological warfare agent released by China?

  • yes

    Votes: 175 89.3%
  • no

    Votes: 21 10.7%

  • Total voters
    196

Indrajit

Senior Member
Joined
Feb 27, 2018
Messages
4,098
Likes
15,588
Country flag
Pharma industry is already powerful in India and we all know that. India is basically pharmacy of the world. And don't make it a cong vs BJP thing.

we have only 0.65 doctors, 1.3 nurses and 1.3 hospital beds per 1,000 people in the country and you talk about enough is done :D

Tourism is good but not at an expense of lives of millions.
The figures for Doctors, nurses etc cant be changed anytime soon. There are hospitals built in many places which are lying empty because there is no staff available. We can make a start by banning all Indian doctors from ever leaving the shores but even if that withstood legal scrutiny, would it solve the problems even a little? Doctors aren't n a rush to serve in rural areas or smaller towns, there is a problem there that won't get solved with just another hospital being built. you are right that we have a problem there but like so many of our problems, there are no easy solutions.
 

vampyrbladez

Senior Member
Joined
Jun 21, 2018
Messages
10,261
Likes
26,567
Country flag
With limited resources what India has achieved is incredible and we all should praise that but what I said has nothing to do with comparison with Uk or US. I am specifically talking about the worst conditions our health care system is. Do you think 500 million Indians can afford your private hospitals?
If you have a system like Ayushman Bharat linked to individual plans then possibility increases greatly.
 

Craigs

Senior Member
Joined
Sep 22, 2016
Messages
1,402
Likes
3,382
Country flag
Coronavirus crisis: DRDO working with Tata, Mahindra on 'multi-patient ventilators'
It is estimated that India has only about 40,000 ventilators at present, including about 8,500 in public hospitals
PB Jayakumar | New Delhi, Saturday, March 28, 2020 | 15:22 IST
screenshot_2020_03_24_at_443_505_280320025819.jpg
The Defence Research and Development Organisation (DRDO) is trying to develop 'multi-patient ventilators', wherein several patients can be supported by a single ventilator to meet the huge demand if the Covid-19 outbreak goes out of control.

"This innovation is expected to be available within a week. Around 5,000 ventilators will be produced in the first month and 10,000 subsequently. The DRDO has identified local alternatives to the supply of critical components. Already Secretary (Pharmaceuticals) has identified nine companies for design transfer to produce and Anand Mahindra for the fabrication of components. Each ventilator unit will cost around Rs four lakh," the government said in a statement.

It said since COVID-19 affects pulmonary functions, keeping in mind the futuristic requirement, the Society for Biomedical Technology (SBMT) programme of the DRDO has been modified to cater to the current situation. Defence Bio-Engineering and Electro Medical Laboratory (DEBEL), Bangalore (a DRDO lab), has identified a vendor, Scanray Tech, Mysore, to produce critical care ventilator. It has been created by using existing technologies like breath regulators, pressure/flow sensors, etc.

Reportedly, the Union government has already reached out to five automakers -- Tata Motors, Mahindra and Mahindra (M&M), Hyundai Motor India, Honda Cars India and Maruti Suzuki India to explore the possibility of making ventilators at their plants.

It is estimated that India has only about 40,000 ventilators at present, including about 8,500 in public hospitals. Kerala, which currently has the largest number of COVID 19 patients, has about 5,000 ventilators; Mumbai has less than 1,000; 1,500 in Tamil Nadu; and 1,800 in Madhya Pradesh.


In some eastern states, the number of ventilators is in single digits. The Health Ministry has reportedly asked a public sector unit to make 10,000 ventilators and another 30,000 would be supplied by Bharat Electricals, a PSU under the Ministry of Defence, by June, Health Ministry Joint Secretary Lav Agarwal has said.

The move to invite corporates to make multi-patient ventilators is also being experimented by the United States, where the number of COVID-19 patients has crossed over a lakh. Major auto giants like Ford and General Motors are working on war footing to manufacture ventilators. On Friday, Ventec Life Systems and General Motors announced a partnership to produce more than 10,000 ventilators per month starting as early as April.

( this is how we provide medical treatment it's of no Use to build junk worthy medical hospitals which have no facilities and not even private hospitals can afford such expensive machines but now government have allowed DRDO to share it's ventilators design to priavte sector DRDO created ventilators approximately A decade back but toT was never transferred to priavte sector.)
Ventilators are over-hyped. Once patient is on it, it is ram nam satya hai. Effort should be to avoid ventilator not require one.
 

Assassin 2.0

Senior Member
Joined
Aug 13, 2019
Messages
6,087
Likes
30,705
Country flag
Ventilators are over-hyped. Once patient is on it, it is ram nam satya hai. Effort should be to avoid ventilator not require one.
Most of the time when oldies go on ventilators chances of their survivability is low but i have personally seen many people which have been able to get back from ventilators. Sometimes new born babies have difficulty to breath so to support them ventilators are required.
Ventilators is certainly not over-hyped with the correct case and age people do get saved because of that machine but issue is they are very expensive in india.
 

Absolut_Vodka

Quarantined Abdul
Banned
Joined
Feb 16, 2019
Messages
1,413
Likes
7,071
Country flag
I think complete lockdown should have stayed for 2 more weeks (in Red and Orange zones) as India is scaling testing upto 1 lakh per day. It would have been real beneficial compared to first 3 weeks lockdown when we had testing capacity from 5k to 30k. We would have taken 28000 more coronavirus patients out of cycle estimating we find 2k per day. Plus after 2 weeks we would have scaled testing to 1.5 lakhs.

2 more weeks lockdown would have given dividend of more than 42 days (6 weeks) of initial lockdown.
 
Last edited:

Indrajit

Senior Member
Joined
Feb 27, 2018
Messages
4,098
Likes
15,588
Country flag
Places like Karnataka have almost eased lockdown substantially. They have also been innovative about how to deal with a large city like Bangalore which has the fewest cases of any major metro (huge surprise that) but which under the central government’s terminology is a red zone. They have actually broken down the city into its wards and only two of the 198 wards are in the red zone, 10 in the orange zone, 13 in the yellow zone and the rest in the green zone. Containment zones include both the red wards, 8 of the 10 orange wards and 7 of the 13 yellow wards where restrictions will continue. With industries being given permission to work from the 4th of may, the state is essentially limping back to normal.

I’m not sure how I feel about this, while I agree that we need to allow some economic activity, especially in areas of green zone, I don’t know how well a major city can deal with lockdown being lifted substantially and not have a rise of cases. Hopefully, this attempt would be a success and allow other areas to also follow this pattern as they slowly ease the lockdown.
 

indiatester

Senior Member
Joined
Jul 4, 2013
Messages
5,856
Likes
20,249
Country flag
Total cases today at 37336 (prev: 35043) and
  • Active Status
    26167 Active Cases (prev: 25007)
  • Inactive Status
    9950 Cured / Discharged
  • Death Status
    1218 Deaths
  • Inactive Status
    1 Migrated

Thats a jump of 1160 active. Same yesterday was (1993/1356) compared to day before(1718/1002) .
Check the 2nd plot for the growth numbers (active alone)

View attachment 46755


COVID-19 INDIA as on : 02 May 2020, 08:00 GMT+5:30
Total cases today at 39980 (prev: 37336) and
  • Active Status
    28046 Active Cases (prev: 26167)
  • Inactive Status
    10632 Cured / Discharged
  • Death Status
    1301 Deaths
  • Inactive Status
    1 Migrated

Thats a jump of 1879 active. Same yesterday was (2293/1160) compared to day before(1993/1356) .
This is a big jump. Maharastra?
Check the 2nd plot for the growth numbers (active alone)


1588482573026.png


COVID-19 INDIA as on : 03 May 2020, 08:00 GMT+5:30
 

Indo-Aryan

Regular Member
Joined
Jun 6, 2018
Messages
815
Likes
884
Country flag
It's may guys and the heat isn't there 😑
Has less pollution resulted in below normal average temperatures in april.
 

Absolut_Vodka

Quarantined Abdul
Banned
Joined
Feb 16, 2019
Messages
1,413
Likes
7,071
Country flag
Total cases today at 39980 (prev: 37336) and
  • Active Status
    28046 Active Cases (prev: 26167)
  • Inactive Status
    10632 Cured / Discharged
  • Death Status
    1301 Deaths
  • Inactive Status
    1 Migrated

Thats a jump of 1879 active. Same yesterday was (2293/1160) compared to day before(1993/1356) .
This is a big jump. Maharastra?
Check the 2nd plot for the growth numbers (active alone)


View attachment 46862

COVID-19 INDIA as on : 03 May 2020, 08:00 GMT+5:30
You ought to find huge jumps because we are testing roughly three times of our previous capacity. So that's 3 days value in previous lockdown, i.e, 1800/3 = 600 per day.
 

Holy Triad

Tihar Jail
Banned
Joined
Dec 16, 2018
Messages
4,110
Likes
24,158
Country flag
Covid scare
@crpfindia
HQ in Delhi. One Driver attached with CRPF Hqr has tested COVID Positive. CRPF Hqr is closed (sealed) for sanitisation till the task is completed. Earlier 135 crpf personnel from 31 Battalion in Delhi have tested positive. Results of 20 more awaited.


 

afako

Hindufying India
Senior Member
Joined
Aug 18, 2010
Messages
3,722
Likes
21,194
Country flag
Chinese study finds hydroxychloroquine useful in controlling Covid mortality

As some Western studies found hydroxychloroquine ineffective as a potential Covid-19 therapy, a new Chinese research has reported that the anti-malarial drug brought down mortality rates significantly among critical coronavirus patients.

The latest preprint study -- which means it's not yet peer-reviewed -- is based on the clinical analysis of 568 Covid-19 cases at Tongji Hospital in Wuhan, the initial epicentre of the pandemic, between February 1 and April 8.

Funded by China's Ministry of Science and Technology, Nature Science Foundation and Ma Yun Foundation, the research is sent to the Science China Life Sciences journal for peer-reviewing.

According to this research, all patients under the clinical analysis received comparable basic treatments, including antiviral and antibiotic drugs, and 48 of them received oral HCQ therapy for seven-ten days additionally.

The mortality rate in the HCQ group stood at 18.8 percent against 43.5 percent in the non-HCQ group, the study noted.

1588490981454.png


"Hydroxychloroquine treatment is significantly associated with a decreased mortality in critically-ill Covid-19 patients," the researchers wrote.

The study claims to "demonstrate that hydroxychloroquine application is associated with a decreased risk of death in critically-ill Covid-19 patients without obvious toxicity".

It recommends that "hydroxychloroquine should be considered a primary option to apply to treat critically-ill Covid-19 patients, which could save lives during the current Covid-19 pandemic".

The Chinese researchers, however, also suggest that despite their findings, the randomized double-blind-control study was needed to provide stronger evidence.

Encouraged by the results, Turkey is now relaxing some of the lockdown measures.

HCQ treatment, said Istanbul University President Nuri Aydin, is "one of the main steps" in Covid-19 treatment. "...the second is isolation," news reports quoted Dr Aydin as having said.

In the US, the Association of American Physicians and Surgeons found there are "about 90 percent chances of HCQ helping Covid-19 patients".

But another retrospective study associated with the US veterans claimed that the treatment had no positive effect on the 97 patients given HCQ doses.

In another study published in the May issue of The Federation of American Societies for Experimental Biology (FASEB), researchers from the Harvard Medical School concluded that HCQ was ineffective against Covid-19.

US drug regulators on Friday gave emergency-use authorization for COVID-19 treatment to anti-Ebola drug remdesivir, whereas several US hospitals continue to use HCQ to treat coronavirus patients.

In India, HCQ remains the first line of therapeutic defence in the battle against Covid-19.

India, meantime, raised the production of HCQ tablets to 30 crore in April from 12.23 crore a month before.

Several countries including Brazil, Israel, Australia, Canada continue to use HCQ in Covid-19 cases.
 

Global Defence

New threads

Articles

Top